Teenagers with type 1 diabetes now have the first randomized trial evidence that an SGLT2 inhibitor can protect their kidneys ...

It doesn’t take much to find all sorts of claims online and elsewhere (books, podcasts, diets, advertising) promising wellness and longevity. So many products. So many medications. What About the ...

Researchers in Germany determine that flower strips and legume mixtures hold statistically significant benefits in terms of ...

Recent evidence on cash transfers and child health is mixed, suggesting that cash transfers may be a necessary but ...

AI makes the first 80% of development feel fast, but hides architectural complexity until it's too late. To prevent system ...

Tesamorelin can selectively reduce visceral fat, as demonstrated in RCTs. But the real story is what it reveals about ...

Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...